Author

Chief Marketer Staff

  • Travelzoo Ups Search ROI

    Internet media company Travelzoo relies on persuading people to give in to that spur-of-the-moment travel impulse. In fact, Erik Qualman, head of North

  • Defending Your Movie

    If you’re driving around Los Angeles or New York anytime next month, you might see ads that depict images of suicide, such as people electrocuting themselves

  • The Industry Needs an Ombudsman

    I don’t remember the name of a science-fiction film I saw some years ago, but I remember the plot: An evil serpent (is there any other kind, in fiction?)

  • Driving Diversity

    Car racing inherently has its risks. So it makes perfect sense for Allstate to be the official insurance company for NASCAR. It also makes sense that

  • Listline

    NEW LISTS Gevalia SOHO Continuity Buyers Approximately 1.3 million businesspeople who responded to a trial delivery offer for coffee and a free coffeemaker

  • The Cross-Channel Advantage

    The retail market has changed dramatically in recent years. Today just about every company that wants to stay relevant to its customer base is multichannel. This has made it essential for retailers of every stripe to optimize technology and business disciplines on the Web, in print catalogs, in brick-and-mortar stores — and beyond.

  • Jackpot!

    An iconic board game like Monopoly is recognized throughout the world. And its maker is capitalizing on that notoriety by expanding a licensing deal to

  • Let’s Get Together

    If you want to make friends, you have to be social. The same theory applies if you want to court customers, says Valerie Fox, vice president of social networking site Gather.com.

  • The Upstarts

    Each year, Direct gathers a roomful of list industry professionals to discuss the ins and outs of the brokerage and management world. Our panels typically have consisted of the

  • RX: ONLINE

    Both consumers and physicians alike research medical treatments online. So it’s of no surprise that a new survey found that drug makers are spending more